Gibbs Andrew

Avg. Two Year Performance

No purchase track record
37% Avg. Sale Return
17% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return2%(3%)(2%)2%37%
Sale Success Rate1 of 10 of 10 of 11 of 11 of 1

Myrexis, Inc.

Drugs » Drug Manufacturers - Major

VP, General Counsel:

Holdings: 19.85K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--